Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris
L Iversen - British Journal of Dermatology, 2015 - academic.oup.com
Background Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld, L Iversen, S Lasthein… - ikm.ku.dk
BACKGROUND: Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long-term therapeutic performance in a real-life setting …
important parameter reflecting the long-term therapeutic performance in a real-life setting …
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld, L Iversen… - British Journal of …, 2015 - research.regionh.dk
BACKGROUND: Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long-term therapeutic performance in a real-life setting …
important parameter reflecting the long-term therapeutic performance in a real-life setting …
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld… - The British journal …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long-term therapeutic performance in a real-life setting …
important parameter reflecting the long-term therapeutic performance in a real-life setting …
Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld, L Iversen… - British Journal of …, 2015 - Wiley Online Library
Background Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.
R Gniadecki, B Bang, LE Bryld, L Iversen… - The British Journal of …, 2014 - europepmc.org
Background Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long-term therapeutic performance in a real-life setting …
important parameter reflecting the long-term therapeutic performance in a real-life setting …
Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld, L Iversen… - British Journal of …, 2015 - infona.pl
Background Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R Gniadecki, B Bang, LE Bryld… - British Journal of …, 2015 - portal.findresearcher.sdu.dk
BACKGROUND: Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long-term therapeutic performance in a real-life setting …
important parameter reflecting the long-term therapeutic performance in a real-life setting …